Understanding how to block the bitter taste of HIV/AIDS medications
Molecular mechanism of the bitter taste of HIV/AIDS drugs and its inhibition
This study is looking for ways to make HIV/AIDS medications taste better for infants and young children, so they can take their medicine more easily without the unpleasant bitterness.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northeastern University NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10656567 on NIH RePORTER |
What this research studies
This research aims to explore the molecular mechanisms that cause the bitter taste of HIV/AIDS drugs, particularly focusing on how to inhibit this taste to improve medication adherence. It is especially important for infants and young children who often struggle to take these medications due to their unpleasant flavor. The researchers will use computational models and experimental testing to identify specific blockers that can mask the bitterness of these drugs. By developing these taste blockers, the goal is to ensure that children receive their necessary medication without the challenge of a bitter taste.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants and young children who require HIV/AIDS medications and have difficulty swallowing pills or consuming bitter-tasting liquids.
Not a fit: Patients who are adults or those who do not experience issues with the taste of their medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of medications that are easier for children to take, improving their health outcomes.
How similar studies have performed: While the approach of blocking bitter taste is innovative, similar strategies have shown promise in other areas of pediatric medicine, indicating potential for success.
Where this research is happening
Boston, United States
- Northeastern University — Boston, United States (Active)
Researchers
- Principal investigator: Cui, Meng — Northeastern University
- Study coordinator: Cui, Meng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.